Melbourne's Genetic Technologies (ASX:GTG) has revealed that its genetic test for breast cancer risk, BREVAGen, is gaining traction in the US. [ + ]

Marking International Clinical Trials Day 2012 (20 May), AusBiotech calls on the Government to complete the Clinical Trials Action Group (CTAG) change program to strengthen Australian’s position as a destination for clinical trials. [ + ]

Platypuses on the Australian mainland and in Tasmania are fighting fit but those on small islands are at high risk of being wiped out from disease, according to a University of Sydney study. [ + ]

An exciting breakthrough on the potential anti-skin-cancer properties of the tropical fruit mangosteen has earned its researcher, Flinders University PhD candidate Jing Jing Wang, a seat in the finals of a prestigious medical prize. [ + ]

A new class of anticancer drugs which control the growth and spread of cancers and do so with minimal side effects is being developed by researchers at the University of Sydney. [ + ]

The relativistic Hall effect, describing objects rotating at speeds comparable with the speed of light, has now been reported. The work sheds light on aspects of fundamental physics, and you can demonstrate some aspects of this with your mobile phone. [ + ]

Translating the discovery of a potential cancer biomarker into a genuine diagnostic is tricky business, but it’s worth persevering, says Clincal Genomics CEO, Dr Lawrence LaPointe. [ + ]

Australian researchers have identified genes that can be used to detect the presence of bowel cancer, raising hopes of a new cost-effective blood test. [ + ]

Plexpress, developer of the innovative TRAC platform for high-throughput gene expression analysis, has announced a collaboration with the contract research organisation Admescope which will now include TRAC as part of its services for investigating in vitro drug interactions and preclinical ADME-Tox responses. [ + ]

Patients enrolled in a pilot trial of REVA Medical's (ASX:RVA) ReZolve coronary stent have so far suffered no major adverse coronary events. [ + ]

ResMed (ASX:RMD) is hunting internally and externally for a new CEO to replace founter Dr Peter Farrell when he steps down as CEO at the end of 2013. [ + ]

The main technical difficulty in building a quantum computer could soon be the thing that makes it possible to build one, according to new research from the Australian National University (ANU). [ + ]

Mettler Toledo and Konica Minolta Sensing have decided to join forces with a strategic partnership in the field of multiparameter analysis for the food and flavours, and fragrances industry. The partnership will bundle the CM-5 or CR-5 Spectrophotometer from Konica Minolta with the density, refractive index and pH instruments from Mettler Toledo to provide a complete system for automatic quality monitoring of raw materials and finished goods. [ + ]

As a further foray into social media and communication technologies, AusBiotech this week launched a web app at the AusMedtech 2012 conference that gave delegates access to all the event information in an easy and fun web format. [ + ]

One of Australia’s foremost astronomers, Professor Matthew Colless, has, today, been announced as the new Director of the Research School of Astronomy and Astrophysics at The Australian National University (ANU). [ + ]